Author
Listed:
- Melanie Almeida
(Vienna BioCenter (VBC)
Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC))
- Matthias Hinterndorfer
(Vienna BioCenter (VBC)
Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC))
- Hanna Brunner
(Vienna BioCenter (VBC)
Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC))
- Irina Grishkovskaya
(Vienna BioCenter (VBC))
- Kashish Singh
(Vienna BioCenter (VBC)
MRC Laboratory of Molecular Biology)
- Alexander Schleiffer
(Vienna BioCenter (VBC))
- Julian Jude
(Vienna BioCenter (VBC)
Twist Bioscience)
- Sumit Deswal
(Vienna BioCenter (VBC)
AstraZeneca)
- Robert Kalis
(Vienna BioCenter (VBC)
Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC))
- Milica Vunjak
(Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC)
University of Vienna, Vienna BioCenter (VBC))
- Thomas Lendl
(Vienna BioCenter (VBC))
- Richard Imre
(Vienna BioCenter (VBC))
- Elisabeth Roitinger
(Vienna BioCenter (VBC))
- Tobias Neumann
(Vienna BioCenter (VBC)
Quantro Therapeutics)
- Susanne Kandolf
(Vienna BioCenter (VBC))
- Michael Schutzbier
(Vienna BioCenter (VBC))
- Karl Mechtler
(Vienna BioCenter (VBC))
- Gijs A. Versteeg
(University of Vienna, Vienna BioCenter (VBC))
- David Haselbach
(Vienna BioCenter (VBC))
- Johannes Zuber
(Vienna BioCenter (VBC)
Medical University of Vienna, Vienna BioCenter (VBC))
Abstract
Protein expression and turnover are controlled through a complex interplay of transcriptional, post-transcriptional and post-translational mechanisms to enable spatial and temporal regulation of cellular processes. To systematically elucidate such gene regulatory networks, we developed a CRISPR screening assay based on time-controlled Cas9 mutagenesis, intracellular immunostaining and fluorescence-activated cell sorting that enables the identification of regulatory factors independent of their effects on cellular fitness. We pioneered this approach by systematically probing the regulation of the transcription factor MYC, a master regulator of cell growth1–3. Our screens uncover a highly conserved protein, AKIRIN2, that is essentially required for nuclear protein degradation. We found that AKIRIN2 forms homodimers that directly bind to fully assembled 20S proteasomes to mediate their nuclear import. During mitosis, proteasomes are excluded from condensing chromatin and re-imported into newly formed daughter nuclei in a highly dynamic, AKIRIN2-dependent process. Cells undergoing mitosis in the absence of AKIRIN2 become devoid of nuclear proteasomes, rapidly causing accumulation of MYC and other nuclear proteins. Collectively, our study reveals a dedicated pathway controlling the nuclear import of proteasomes in vertebrates and establishes a scalable approach to decipher regulators in essential cellular processes.
Suggested Citation
Melanie Almeida & Matthias Hinterndorfer & Hanna Brunner & Irina Grishkovskaya & Kashish Singh & Alexander Schleiffer & Julian Jude & Sumit Deswal & Robert Kalis & Milica Vunjak & Thomas Lendl & Richa, 2021.
"AKIRIN2 controls the nuclear import of proteasomes in vertebrates,"
Nature, Nature, vol. 599(7885), pages 491-496, November.
Handle:
RePEc:nat:nature:v:599:y:2021:i:7885:d:10.1038_s41586-021-04035-8
DOI: 10.1038/s41586-021-04035-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Chrysanthi Kagiou & Jose A. Cisneros & Jakob Farnung & Joanna Liwocha & Fabian Offensperger & Kevin Dong & Ka Yang & Gary Tin & Christina S. Horstmann & Matthias Hinterndorfer & Joao A. Paulo & Natali, 2024.
"Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation,"
Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Gang Xue & Jianing Xie & Matthias Hinterndorfer & Marko Cigler & Lara Dötsch & Hana Imrichova & Philipp Lampe & Xiufen Cheng & Soheila Rezaei Adariani & Georg E. Winter & Herbert Waldmann, 2023.
"Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
- Edoardo Ratto & S. Roy Chowdhury & Nora S. Siefert & Martin Schneider & Marten Wittmann & Dominic Helm & Wilhelm Palm, 2022.
"Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:599:y:2021:i:7885:d:10.1038_s41586-021-04035-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.